Allogeneic haematopoietic cell transplantation for diffuse large B cell lymphoma: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

被引：2

作者：

Gauthier, Jordan ^{[1
,2
,8
]}

Chantepie, Sylvain ^{[3
,8
]}

Bouabdallah, Krimo ^{[4
,8
]}

Jost, Edgar ^{[5
,8
]}

Nguyen, Stephanie ^{[6
,8
]}

Gac, Anne-Claire ^{[3
,8
]}

Damaj, Gandhi ^{[3
,8
]}

Dulery, Remy ^{[5
,8
]}

Michallet, Mauricette ^{[7
,8
]}

Delage, Jeremy ^{[8
,9
]}

Lewalle, Philippe ^{[8
,10
]}

Morschhauser, Franck ^{[2
,8
]}

Salles, Gilles ^{[8
]}

Yakoub-Agha, Ibrahim ^{[8
,11
]}

Cornillon, Jerome ^{[8
]}

机构：

[1] CHRU Lille, Pole Specialtes Med & Gerontol Secteur Allogre Ce, F-59037 Lille, France

[2] Univ Lille, UFR Med, F-59000 Lille, France

[3] Hop La Pitie Salpetrisre, AP HP, Paris, France

[4] CHU Caen, Serv Hematol, Caen, France

[5] Hop St Antoine, AP HP, Serv Hematol, Paris, France

[6] CHU Lyon, Serv Hematol, Lyon, France

[7] Univ Klinikum Aachen, Klin Onkol Hamatol & Stammzelltransplantat, Aachen, Germany

[8] CHU Montpellier, Serv Hematol, Montpellier, France

[9] Univ Libre Bruxelles, Inst Jules Bordet, Serv Hematol, Brussels, Belgium

[10] Univ Lille 2, CHU Lille, LIRIC Inserm U995, F-59000 Lille, France

[11] Inst Cancerol Lucien Neuwirth, Dept Hematol Clin, St Priest En Jarez, France

来源：

BULLETIN DU CANCER | 2017年 / 104卷 / 12期

关键词：

Allogeneic stem cell; transplantation; Lymphoma; Guidelines; NON-HODGKIN-LYMPHOMA; HIGH-RISK LYMPHOMA; REDUCED-INTENSITY; AUTOLOGOUS TRANSPLANTATION; CONDITIONING REGIMENS; EMISSION TOMOGRAPHY; RITUXIMAB ERA; RELAPSE; IMPACT; OUTCOMES;

D O I：

10.1016/j.bulcan.2017.10.018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic hematopoietic cell transplantation is a potentially curative option, this is true particularly in the case of after autologous stem cell transplantation if remission can be achieved. Recently, novel agents such as anti-PD1 and BTK inhibitors have started to challenge the use of allogeneic hematopoietic cell transplantation for relapsed or refractory lymphoma. During the 2016 annual workshop of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC), we performed a comprehensive review of the literature published in the last 10 years and established guidelines to clarify the indications and transplant modalities in this setting. This section specifically reports on our conclusions regarding diffuse large B cell lymphoma.

引用

页码：S131 / S135

页数：5

共 27 条

[1] [Anonymous], AM SOC HEMATOL ED PR, DOI DOI 10.1182/ASHEDUCATI0N-2016.1.366
[2] Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: Importance of histology for outcome
Armand, Philippe
Kim, Haesook T.
Ho, Vincent T.
Cutler, Corey S.
Koreth, John
Antin, Joseph H.
LaCasce, Ann S.
Jacobsen, Eric D.
Fisher, David C.
Brown, Jennifer R.
Canellos, George P.
Freedman, Arnold S.
Soiffer, Rohert J.
Alyea, Edwin P.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (04) : 418 - 425
[3] Impact of Pretransplantation 18F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma
Bachanova, Veronika
Burns, Linda J.
Ahn, Kwang Woo
Laport, Ginna G.
Akpek, Goerguen
Kharfan-Dabaja, Mohamed A.
Nishihori, Taiga
Agura, Edward
Armand, Philippe
Jaglowski, Samantha M.
Cairo, Mitchell S.
Cashen, Amanda F.
Cohen, Jonathon B.
D'Souza, Anita
Freytes, Cesar O.
Gale, Robert Peter
Ganguly, Siddhartha
Ghosh, Nilanjan
Holmberg, Leona A.
Inwards, David J.
Kanate, Abraham S.
Lazarus, Hillard M.
Malone, Adriana K.
Munker, Reinhold
Mussetti, Alberto
Norkin, Maxim
Prestidge, Tim D.
Rowe, Jacob M.
Satwani, Prakash
Siddiqi, Tanya
Stiff, Patrick J.
William, Basem M.
Wirk, Baldeep
Maloney, David G.
Smith, Sonali M.
Sureda, Anna M.
Carreras, Jeanette
Hamadani, Mehdi
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (09) : 1605 - 1611
[4] Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Bacher, Ulrike
Klyuchnikov, Evgeny
Le-Rademacher, Jennifer
Carreras, Jeanette
Armand, Philippe
Bishop, Michael R.
Bredeson, Christopher N.
Cairo, Mitchell S.
Fenske, Timothy S.
Freytes, Cesar O.
Gale, Robert Peter
Gibson, John
Isola, Luis M.
Inwards, David J.
Laport, Ginna G.
Lazarus, Hillard M.
Maziarz, Richard T.
Wiernik, Peter H.
Schouten, Harry C.
Slavin, Shimon
Smith, Sonali M.
Vose, Julie M.
Waller, Edmund K.
Hari, Parameswaran N.
[J]. BLOOD, 2012, 120 (20) : 4256 - 4262
[5] Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation
Bishop, M. R.
Dean, R. M.
Steinberg, S. M.
Odom, J.
Pavletic, S. Z.
Chow, C.
Pittaluga, S.
Sportes, C.
Hardy, N. M.
Gea-Banacloche, J.
Kolstad, A.
Gress, R. E.
Fowler, D. H.
[J]. ANNALS OF ONCOLOGY, 2008, 19 (11) : 1935 - 1940
[6] Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma
Chen, Yi-Bin
Li, Shuli
Fisher, David C.
Driscoll, Jessica
Del Rio, Candice
Abramson, Jeremy
Armand, Philippe
Barnes, Jeffrey
Brown, Jennifer
Cutler, Corey
El-Jawahri, Areej
Ho, Vincent T.
Hochberg, Ephraim
McAfee, Steven
Takvorian, Ronald
Spitzer, Thomas R.
Antin, Joseph H.
Soiffer, Robert
Jacobsen, Eric
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (09) : 1583 - 1588
[7] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
Cheson, BD
Horning, SJ
Coiffier, B
Shipp, MA
Fisher, RI
Connors, JM
Lister, TA
Vose, J
Grillo-López, A
Hagenbeek, A
Cabanillas, F
Klippensten, D
Hiddemann, W
Castellino, R
Harris, NL
Armitage, JO
Carter, W
Hoppe, R
Canellos, GP
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) : 1244 - 1253
[8] Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma
Crocchiolo, R.
Castagna, L.
Fuerst, S.
EI-Cheikh, J.
Faucher, C.
Oudin, C.
Granata, A.
Bouabdallah, R.
Coso, D.
Chabannon, C.
Balzarotti, M.
Santoro, A.
Blaise, D.
[J]. BONE MARROW TRANSPLANTATION, 2013, 48 (02) : 249 - 252
[9] Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients
Crocchiolo, Roberto
Castagna, Luca
Garciaz, Sylvain
Fuerst, Sabine
El Cheikh, Jean
Sarina, Barbara
Bramanti, Stefania
Granata, Angela
Vai, Andrea
Harbi, Samia
Morabito, Lucio
Mohty, Bilal
Giordano, Laura
Devillier, Raynier
Coso, Diane
Balzarotti, Monica
Chabannon, Christian
Carlo-Stella, Carmelo
Santoro, Armando
Bouabdallah, Reda
Blaise, Didier
[J]. HAEMATOLOGICA, 2015, 100 (10) : E423 - E427
[10] Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients
Fenske, Timothy S.
Hamadani, Mehdi
Cohen, Jonathon B.
Costa, Luciano J.
Kahl, Brad S.
Evens, Andrew M.
Hamlin, Paul A.
Lazarus, Hillard M.
Petersdorf, Effie
Bredeson, Christopher
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (09) : 1543 - 1551

← 1 2 3 →